NDC 42806-260

GEMFIBROZIL

Gemfibrozil

GEMFIBROZIL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Epic Pharma, Llc. The primary component is Gemfibrozil.

Product ID42806-260_4954c1d9-ab30-487e-8837-2e7a1d4112e6
NDC42806-260
Product TypeHuman Prescription Drug
Proprietary NameGEMFIBROZIL
Generic NameGemfibrozil
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-03-23
Marketing CategoryANDA / ANDA
Application NumberANDA078012
Labeler NameEpic Pharma, LLC
Substance NameGEMFIBROZIL
Active Ingredient Strength600 mg/1
Pharm ClassesPeroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 42806-260-05

500 TABLET in 1 BOTTLE (42806-260-05)
Marketing Start Date2017-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 42806-260-60 [42806026060]

GEMFIBROZIL TABLET
Marketing CategoryANDA
Application NumberANDA078012
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-03-23

NDC 42806-260-18 [42806026018]

GEMFIBROZIL TABLET
Marketing CategoryANDA
Application NumberANDA078012
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-03-23

NDC 42806-260-05 [42806026005]

GEMFIBROZIL TABLET
Marketing CategoryANDA
Application NumberANDA078012
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-03-23

Drug Details

Active Ingredients

IngredientStrength
GEMFIBROZIL600 mg/1

OpenFDA Data

SPL SET ID:77bb947a-340c-4592-b56d-bc77fb17e753
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310459
  • UPC Code
  • 0342806260609
  • Pharmacological Class

    • Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]
    • PPAR alpha [CS]
    • Peroxisome Proliferator Receptor alpha Agonist [EPC]

    Medicade Reported Pricing

    42806026060 GEMFIBROZIL 600 MG TABLET

    Pricing Unit: EA | Drug Type:

    42806026005 GEMFIBROZIL 600 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "GEMFIBROZIL" or generic name "Gemfibrozil"

    NDCBrand NameGeneric Name
    0093-0670GemfibrozilGemfibrozil
    0143-9130GemfibrozilGemfibrozil
    0143-9707GemfibrozilGemfibrozil
    0179-0221GemfibrozilGemfibrozil
    0615-3559GemfibrozilGemfibrozil
    0615-8354GemfibrozilGemfibrozil
    10544-569GemfibrozilGemfibrozil
    16571-784GemfibrozilGemfibrozil
    16714-101Gemfibrozilgemfibrozil
    21695-732GemfibrozilGemfibrozil
    24658-260GemfibrozilGemfibrozil
    31722-128GEMFIBROZILGemfibrozil
    31722-225GemfibrozilGemfibrozil
    33261-146GemfibrozilGemfibrozil
    42806-260GEMFIBROZILGEMFIBROZIL
    43063-745GemfibrozilGemfibrozil
    43063-921GEMFIBROZILGEMFIBROZIL
    43353-090GemfibrozilGemfibrozil
    43353-772GemfibrozilGemfibrozil
    43602-452GEMFIBROZILGemfibrozil
    50090-0458GemfibrozilGemfibrozil
    50090-2450GemfibrozilGemfibrozil
    50090-2902GemfibrozilGemfibrozil
    50090-5808GEMFIBROZILGemfibrozil
    50268-350GemfibrozilGemfibrozil
    68071-1733GemfibrozilGemfibrozil
    68071-4053GEMFIBROZILGEMFIBROZIL
    68071-4011GEMFIBROZILGEMFIBROZIL
    68071-4631GemfibrozilGemfibrozil
    68071-4421GemfibrozilGemfibrozil
    68151-2893GemfibrozilGemfibrozil
    68382-553GemfibrozilGemfibrozil
    68788-6447GemfibrozilGemfibrozil
    68788-7011GEMFIBROZILGEMFIBROZIL
    68788-9149GemfibrozilGemfibrozil
    69097-821GemfibrozilGemfibrozil
    70518-1563GemfibrozilGemfibrozil
    70518-1301GemfibrozilGemfibrozil
    70771-1431GemfibrozilGemfibrozil
    71205-169GemfibrozilGemfibrozil
    71209-008GemfibrozilGemfibrozil
    71335-0051GEMFIBROZILGEMFIBROZIL
    71335-0971GemfibrozilGemfibrozil
    71335-0899GemfibrozilGemfibrozil
    71335-0515GemfibrozilGemfibrozil
    71610-200GemfibrozilGemfibrozil
    71610-107GemfibrozilGemfibrozil
    75834-131GemfibrozilGemfibrozil
    76282-225GemfibrozilGemfibrozil
    50436-6540GemfibrozilGemfibrozil

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.